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Abstract
MicroRNAs (miRNAs) are important regulators of many cellular processes, including
the differentiation and activity of osteoblasts, and therefore, of bone turnover. MiR-320a
is overexpressed in osteoporotic bone tissue but its role in osteoblast function is
unknown. In the present study, functional assays were performed with the aim to eluci-
date the mechanism of miR-320a action in osteoblastic cells. MiR-320a was either over-
expressed or inhibited in human primary osteoblasts (hOB) and gene expression
changes were evaluated through microarray analysis. In addition, the effect of miR-
320a on cell proliferation, viability, and oxidative stress in hOB was evaluated. Finally,
matrix mineralization and alkaline phosphatase activity were assessed in order to evalu-
ate osteoblast functionality. Microarray results showed miR-320a regulation of a num-
ber of key osteoblast genes and of genes involved in oxidative stress. Regulation of
osteoblast differentiation and ossification appeared as the best significant biological
processes (PANTHER P value = 3.74E-05; and P value = 3.06E-04, respectively). The
other enriched pathway was that of the cellular response to cadmium and zinc ions,
mostly by the overexpression of metallothioneins. In hOBs, overexpression of miR-
320a increased cell proliferation and oxidative stress levels whereas mineralization
capacity was reduced. In conclusion, overexpression of miR-320a increased stress oxi-
dation levels and was associated with reduced osteoblast differentiation and functional-
ity, which could trigger an osteoporotic phenotype.
Introduction
MicroRNAs (miRNAs) are considered important regulators of cellular processes related to
bone metabolism, among others. A number of miRNAs have been reported to regulate the
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differentiation and activity of osteoblasts and osteoclasts by targeting genes with a key role in
bone turnover [1], although the full mechanism of action remains unknown.
Identifying the specific functions of miRNAs in bone may give insights into the patho-
physiology of skeletal disorders. For example, a microarray analysis has shown overexpres-
sion of miR-320a in whole bone tissue from women with osteoporotic fracture [2, 3].
Moreover, miR-320a is elevated in osteoarthritic cartilage tissue and chondrocytes [4],
highlighting its potential functionality in the musculoskeletal system. This miRNA has been
reported to have multiple mRNA targets and to regulate different pathways in various cell
types. To date, most studies on miR-320a involve cancer malignancies [5–8], followed by
other pathologies such as cardiovascular diseases [9, 10] or Type II diabetes [11, 12]. In
bone tissue, miR-320a is expressed in human primary osteoblasts (hOBs) and in differenti-
ated osteoclasts (hOCs) and is predicted to regulate genes involved in bone metabolism [2,
13]. Recently, Huang et al. [14] demonstrated that miR-320a inhibits the osteogenic differ-
entiation of mesenchymal stem cells by targeting HOXA10. This is consistent with a previ-
ous study showing downregulation of miR-320a during osteogenic differentiation of
fibroblasts in vitro [15]. However, the role of miR-320a in the context of bone and in differ-
entiated osteoblasts has not been explored.
In the present study, we performed functional assays with the aim to elucidate the mecha-
nism of miR-320a action in osteoblastic cells. For this purpose, miR-320a was either overex-
pressed or inhibited in hOB and gene expression changes were assessed through microarray
analysis. In addition, osteoblast functionality was evaluated by assessing matrix mineralization
and alkaline phosphatase (ALP) activity. Finally, the effect of miR-320a on cell proliferation,
viability, and oxidative stress was evaluated.
Materials and methods
Cell culture
Human primary osteoblasts (hOBs) were obtained from fresh trabecular bone from postmeno-
pausal women subject to a knee transplant surgery due to osteoarthritis. Exclusion criteria
were any history of metabolic or endocrine disease, chronic renal failure, chronic liver disease,
malignancy, Paget’s disease of bone, malabsorption syndrome, and any bone metabolism-
affecting treatment. The study was carried out in accordance with the Declaration of Helsinki,
and the approved protocol for obtaining primary osteoblasts from knee samples otherwise dis-
carded at the time of orthopedic surgery was explained to potential participants. Written
informed consent was obtained from all individual participants included in the study. The
Clinical Research Ethics Committee of Parc de Salut MAR approved the present research (Reg-
istry number 2010/3882/I and 2013/5266/I).
Bone samples were carefully obtained from a location distant from the interface between
bone and cartilage and, therefore, as far away as possible from the osteoarthritic lesion. Bone
tissue was cut up into small pieces, washed in phosphate buffered solution (PBS, Gibco by Life
Technologies; Paisley, UK) to remove non-adherent cells, and cultured on a 140mm culture
plate with Dulbecco’s Modified Eagle Medium (DMEM; Gibco; Invitrogen, Paisley, UK) sup-
plemented with 10% fetal bovine serum (FBS; Sigma-Aldrich; St. Louis, USA), 100 U/ml peni-
cillin/streptomycin (Sigma Aldrich; St. Louis, USA), 0.4% fungizone (Gibco by Life
Technologies; Paisley, UK), and 100 μg/ml ascorbic acid (Sigma-Aldrich; Steinheim, Ger-
many). Bone samples were discarded if patients had a medical history of using oral corticoste-
roids, anti-resorptive or anabolic agents, anti-epileptic drugs, lithium, heparin or warfarin, or
a diagnosis of chronic renal failure, chronic liver disease, malignancy, or metabolic or endo-
crine diseases affecting bone. HOBs were cultured in tissue flasks in DMEM supplemented
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with 10% FBS, 100 U/ml penicillin/streptomycin, and 100 μg/ml ascorbic acid (osteoblastic
medium) until the required number of cells was reached.
Five hOB samples were used for the gene expression microarray, three independent sam-
ples were used for microarray validation by real time PCR, and another six samples were used
for the osteoblast functional assays. All experiments were performed at maximum passage 2.
Cell transfection
Cells were seeded on different well plates depending on the type of experiment to be carried
out after cell transfection. For microarray assay, a 6-well plate with 180,000 cells/well was used.
Two wells were cultured in parallel for qPCR validation of microarray results. To assess cell
viability (MTS), cell proliferation (BrdU), alkaline phosphatase (ALP) activity, and CellRox
Green Reagent assay, a 96-well plate with 12,000 cells/well was used. Finally, a 24-well plate
with 45,000 cells/well was used to perform Alizarin Red assays.
Cells at 70–80% of confluence were transfected with mirVana mimic (M) or inhibitor (I) of
hsa-miR-320a, using Lipofectamine RNAiMAX (Invitrogen; Carlsbad, USA) according to
manufacturer instructions, with the exception of 20 minutes of incubation time for miRNA
-Lipofectamine interaction instead of 5 minutes. MirVana miRNA Mimic Negative Control #1
(CM) and mirVana miRNA Inhibitor Negative Control #1 (CI), respectively, were used as con-
trols. All products were purchased from Ambion Life Technologies (Madrid, Spain). Mimic
and control mimic were used at 100 nM and inhibitor and control inhibitor at 400 nM. In
order to monitor transfection efficiency, miRIDIAN microRNA Mimic Transfection Control
with Dy547 (Dharmacon, 100 nM) was transfected at the same conditions.
Cells transfected with the Mimic Transfection Control with Dy547 were stained with 4’,6-dia-
midino-2-phenylindole (DAPI) dihydrochloride (0’2mg/ml) (Sigma-Aldrich) 24 hours after
transfection to distinguish the nucleus of the cell. Then, cells were observed through the LEICA
DMIL LED fluorescence microscope using the Leica Application Suite (Leica Microsystems).
MiR-320a quantification by quantitative real time PCR (qPCR)
To evaluate the post-transfection miR-320a expression levels in hOBs, total RNA was extracted 48
hours after transfection using the miRNeasy mini kit (Qiagen) according to manufacturer instruc-
tions. Then, 1 μg of total RNA was reverse-transcribed in 20 μl reactions using the miScript II RT
kit (Qiagen). cDNA was diluted 1/8 and 2 μl were assayed in 10 μl qPCR reactions in 384-well
plates using MiScript SYBR Green PCR kit according to the protocol. The mature miR-320a
sequence, according to the mirBase web site, was used as a forward primer (5’-AA AAGCTGGG
TTGAGAGGGCGA-3’) and the Universal primer as a reverse. U6 snRNA was used as the refer-
ence gene for normalization. All qPCR reactions for each sample were performed in triplicate.
Amplification was performed in a QuantStudio 12K Flex Real-Time PCR (Applied Biosystems),
and the ExpressionSuite software v.1.0.3 (Life Technologies) was used both for determination of
relative quantification (RQ) (by 2-ΔΔCt method) and for melting curve analysis.
Gene expression microarray analysis
Changes in gene expression levels at 48 hours after transfection of hOBs (n = 5) with miR-
320a mimic or inhibitor, as well as their respective controls, were measured by microar-
rays. Total RNA from hOBs samples was obtained using the RNeasy mini kit (Qiagen)
according to manufacturer instructions. RNA was assayed by IMIM Microarray Analysis
services (Institut Hospital del Mar d’Investigacions Mèdiques). RNA integrity was
assessed using Agilent 2100 Bioanalyzer (Agilent Technologies). All samples met the qual-
ity standards (RNA integrity number (RIN) >7; Ratio 260/280 > 1,6) and were used in
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microarray experiments. Amplification, labeling, and hybridizations were performed
according to protocol with GeneChip WT PLUS Reagent kit (Affymetrix) and then
hybridized to GeneChip Human Gene 2.0 ST Array in a GeneChip Hybridization Oven
640. Washing and scanning were performed using the Expression Wash and Stain and the
Affymetrix GeneChip System (Fluidics Station 450 and Scanner 3000 7G). After quality
control of raw data, data were background-corrected, quantile-normalized, and summa-
rized to a log2 gene level using the robust multi-chip average (RMA), obtaining a total of
48,144 transcript clusters, excluding controls, which roughly correspond to genes or other
mRNAs such as miRNAs or lincRNAs.
The Log2 Fold Change (Log2FC) was calculated for each sample and gene as ΔM = CM–
M and ΔI = I–CI. The order of the factors in the subtractions was inverted, given that the
expected effect of Mimic and Inhibitor are reverse. Data analyses were performed in R (v
3.1.1) with the aroma.affymetrix package. First analysis selected those genes differentially
expressed between mimic and control mimic samples (ΔM) or between inhibitor and con-
trol inhibitor (ΔI) with a Log2FC >1.5 and P value <0.05, calculated by moderated t-test
[16]. The second analysis selected those genes differentially expressed in both comparisons
(ΔM and ΔI) with a Log2FC >1.2 and P value <0.05 and, moreover, overlapped in both ΔM
and ΔI profiles.
Genes differentially expressed (upregulated and downregulated) underwent a further func-
tional analysis using the Database for Annotation, Visualization and Integrated Discovery
(DAVID) v6.8 [17], PANTHER Classification System [18] and the GeneMANIA prediction
server (http://www.genemania.org) [19].
Gene expression quantification with real time PCR (qPCR)
At 48 hours post-transfection, total RNA extraction of hOBs (n = 3) was performed using the
RNeasy mini kit (Qiagen) according to manufacturer instructions. An additional DNase I
treatment was performed to avoid genomic contamination.
RNA quantity and purity was determined on the ND-2000 Spectrophotometer (NanoDrop
Technologies). Samples for the microarray were stored at -80˚C until use, while samples for
the qPCR were stored at -20˚C.
For qPCR assays, 200 ng of total RNA were retrotranscribed to cDNA following the instruc-
tions of the High-Capacity cDNA Reverse Transcription Kit (Life Technologies). Product was
diluted 1/10 and 2 μl were assayed in 10 μl PCR reactions in 384-well plates using commer-
cially available TaqMan Gene Expression assays (Life Technologies). Gene expression levels
were calculated against beta-actin expression and then normalized to an internal sample (rela-
tive quantification) using arbitrary units.
Cell viability assay (MTS)
Viable cells were determined 48 hours after miR-320a transfection in hOBs (n = 3) using the
CellTiter 96 AQueous One Solution Cell Proliferation Assay (Promega; WI, USA) according
to manufacturer instructions. To measure the amount of soluble formazan produced by cellu-
lar reduction of MTS, the absorbance at 490 nm was measured using a multi-well plate reader
Infinite M200 (Tecan; Gro¨dig, Austria).
Cell proliferation quantification
Proliferation was quantified after 48 h from miR-320a transfection in hOBs (n = 3) based on
the measurement of BrdU incorporation during DNA synthesis with Cell Proliferation Elisa,
BrdU (Colorimetric) (Roche).
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Alizarin red quantification
To quantify mineralization in hOBs (n = 6), Alizarin red assay was performed after 28 days of
culture. Cells were transfected with both mimic and inhibitor of miR-320a and the corre-
sponding controls at day 1 and day 14 after seeding.
Cells were cultured with osteoblastic medium supplemented with 5mM β-glycerophosphate
(Sigma-Aldrich, St Louis, MO, USA); the medium was changed twice per week. At 28 days,
media was removed from the cell monolayer and gently washed three times with PBS. Then,
cells were fixed in 10% buffered formalin for 10 minutes at room temperature. The fixative
was removed and cultures washed with PBS. The cell layer was stained with 2% Alizarin-S
(Sigma- Aldrich, St Louis, MO, USA) at ~pH 4.2 for 20 minutes. Cell preparations were
washed with PBS to eliminate nonspecific staining.
To measure calcium deposition, the dye was leached from the monolayer by the addition of
10% cetylpyridinium chloride until all of the dye had been drawn from the monolayer. At that
point, 100 μl of the solution was transferred to a clean 96-well plate for quantifying spectro-
photometry at 550 nm (using 10% cetylpyridinium chloride as a blank reference).
ALP activity assay
ALP activity was measured in hOBs (n = 3) at 48 hours after miR-320 transfection using the
Alkaline Phosphatase Assay Kit (Colorimetric) (Abcam; Cambridge, UK) according to manu-
facturer instructions.
CellRox Green Reagent assay
Cellular oxidative stress was tested with CellRox Green Reagent (10μM) in 96-well plates at 72
hours after transfection, following manufacturer instructions. Immediately, CellRox Green
Reagent fluorescence was evaluated through the LEICA DMIL LED fluorescence microscope
using the Leica Application Suite (Leica Microsystems). A fluorescence comparison between
mimic and control mimic, inhibitor and control inhibitor was performed using ImageJ (Image
Processing and Analysis in Java) from NIH.
Statistical analysis
Mann-Whitney U test in the SPSS v.12.0 for Windows was performed to establish comparisons
between cells transfected with miRNAs and their respective controls in the Alizarin Red quantifi-
cation, alkaline phosphatase activity, cell proliferation assay and detection of miRNA and mRNA
levels by qPCR. All analyses were two-tailed, and p-values<0.05 were considered significant.
Results
Gene expression analysis after miRNA-320a mimic/inhibitor transfection
in osteoblasts
In order to evaluate the effect of miR-320a on hOB gene expression, a gene microarray analysis
was performed after overexpressing or inhibiting the miR-320a (available in GEO;
GSE121892). As a first step, the efficiency of miRNA transfection was monitored using miRI-
DIAN microRNA Mimic Transfection Control with Dy547 (S1A Fig) and by determining
miR-320a levels after mimic or inhibitor transfection (S1B Fig). Results demonstrated a high
transfection efficiency by increasing the miR-320a levels more than 400-fold after mimic trans-
fection (p = 0.002) and a marked downregulation to residual levels by the inhibitor transfec-
tion (p = 0.002)
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The microarray analysis, using a Log2FC>1.5 and P value<0.05, identified 57 genes differ-
entially expressed in control mimic vs. mimic samples (ΔM). These genes are shown in a hierar-
chical clustering heat map (S2 Fig); those with UCSC annotations are shown in Table 1 (n = 38).
To validate these results, 3 genes (BMP2, PTGS2, and IGFBP1), chosen by known impor-
tance in osteoblastic function, were analyzed using qPCR. All three were confirmed: they
showed significant differences after mimic transfection and in the same direction as that
observed in the microarray (S3 Fig).
Table 1. Differentially expressed genes for ΔM with UCSC annotation.
UCSC symbol LogFC P Value
5S_rRNA 0,74 0,0003
U6 0,73 0,0001
AK056897 0,72 0,0047
GBP1 0,69 0,0377
GDF5 0,67 0,0028
TGOLN2 0,64 0,0000
AK097957//CDCA3 0,62 0,0148
abParts 0,61 0,0005
MIR548Y 0,61 0,0056
SYNGR2 0,60 0,0001
Y_RNA 0,59 0,0141
MIR934//VGLL1 -0,58 0,0029
IFT80 -0,58 0,0308
IER3 -0,59 0,0117
BC065763 -0,61 0,0022
MIR31//IFNE//MIR31HG -0,61 0,0005
DOCK4 -0,62 0,0035
MT1X -0,64 0,0028
PGM2L1 -0,64 0,0448
JARID2 -0,64 0,0495
DKK2 -0,66 0,0001
ITGA2 -0,66 0,0066
MT1G -0,66 0,0010
IGFBP1 -0,69 0,0236
BC045559//SLC6A15 -0,70 0,0039
CDKN2B -0,71 0,0091
AREG -0,71 0,0360
BMP2 -0,72 0,0121
RORB -0,72 0,0006
MT1F -0,74 0,0019
LIF -0,77 0,0408
SLC16A6 -0,78 0,0001
SMOC1 -0,80 0,0025
MET -0,82 0,0006
NPTX1 -0,82 0,0011
MIR4279 -0,84 0,0222
RANBP3L -0,85 0,0037
PTGS2 -0,97 0,0395
https://doi.org/10.1371/journal.pone.0208131.t001
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The same analysis found 41 genes differentially expressed in inhibitor vs. control inhibitor
(ΔI) samples, with a Log2FC >1.5 and P value <0.05, shown in a hierarchical clustering heat
map (S4 Fig); 23 of these genes had UCSC annotations (Table 2). In both heat maps, samples
were grouped according to the transfected RNA (mimic or control, inhibitor or control).
Since no gene was found in both sample clusters (ΔM and ΔI), we performed an additional
analysis, decreasing the Log2FC to>1.2. Using this new threshold, a total of 80 genes overlapped
the ΔM and ΔI profiles. Of these, the 32 genes with UCSC annotations are listed in Table 3.
DAVID tools and PANTHER overrepresentation test analyzing genes from Tables 1, 2 and
3 detected the best enrichment scores in the cellular response to cadmium (P value = 2.07E-
05) and zinc ions (P value = 1.67E-3), which are related to negative regulation of growth
(DAVID enrichment score = 2.8) as well as an enrichment in growth factor and cytokine activ-
ity (P values = 0.014 and 0.017, respectively) with a DAVID enrichment score of 1.5. Regula-
tion of osteoblast differentiation and ossification appeared as best significant biological
processes (PANTHER P value = 3.74E-05; and P value = 3.06E-04, respectively). Mesenchymal
cell differentiation involved in bone development, age-dependent response to oxidative stress,
and positive regulation of Wnt signaling pathway by BMP raised among the top listed fold
enriched pathways in PANTHER analysis. Genemania analysis corroborated these functions
and moreover showed a network containing key genes for bone metabolism: LIF, DKK1,
DKK2, BMP2, GDF5, IGFBP1, IL-6, etc. (Fig 1).
Additionally, key transcription factors involved in the osteoblast differentiation were
assessed by qPCR after transfection with miR-320a mimic or inhibitor and their respective
controls. Among them, HOXA10 [14], RUNX2 [20], and Beta-Catenin [21] are direct targets of
Table 2. Differentially expressed genes for ΔI with UCSC annotation.
UCSC symbol LogFC P Value
PRKDC 0,84 0,0040
SNORD41//TNPO2 0,79 0,0021
TESK2 0,75 0,0000
CR936796 0,73 0,0110
SGMS1 0,72 0,0042
ZNF876P 0,70 0,0021
MAPK6 0,67 0,0417
MIR1234//CPSF1 0,67 0,0026
TPTE 0,67 0,0057
RHOU 0,64 0,0005
SYNPR 0,61 0,0011
KLHL2 0,60 0,0105
MIR3065 0,60 0,0095
EPS8 0,59 0,0012
MIR323A 0,58 0,0387
FLJ41484//GAS6-AS1 0,58 0,0002
ULK4P3 0,58 0,0056
VTRNA1-2 -0,58 0,0437
FPR3 -0,61 0,0122
SNORD115-45//SNURF-SNRPN -0,62 0,0018
SOD2 -0,63 0,0003
KRTAP9-3 -0,69 0,0047
TULP3 -0,87 0,0004
https://doi.org/10.1371/journal.pone.0208131.t002
miR-320a impairs osteoblast function
PLOS ONE | https://doi.org/10.1371/journal.pone.0208131 November 28, 2018 7 / 15
miR-320a. HOXA10 and RUNX2 genes were confirmed in our study as targets of miR-320a
even though differences in RUNX2 gene expression did not reach significant levels (S5 Fig).
Cell viability and proliferation
Primary osteoblast viability and proliferation were assessed after 48 h from transfection with
miR-320a mimic or inhibitor and the respective controls. Neither the transfection of miR-320a
mimic nor that of the inhibitor caused significant changes in cell viability (Fig 2A). On the
other hand, overexpression of miR-320a increased hOB proliferation (P = 0.045) (Fig 2B).
Osteoblastic function
Osteoblast functionality after transfection was evaluated through Alizarin red staining and
alkaline phosphatase activity quantification. Overexpression of miR-320a significantly reduced
matrix mineralization of hOBs (P = 0.02) (Fig 2C) and ALP activity (P = 0.038) (Fig 2D).
Table 3. Overlapped genes between ΔM and ΔI profiles with UCSC annotation. The LogFC is>1.2 and p value<0.05.
UCSC symbol LogFC ΔM P Value ΔM LogFC ΔI P Value ΔI
5S_rRNA 0,74 0,0003 0,37 0,0415
abParts 0,61 0,0005 0,43 0,0097
AK308704//TMEM191C 0,37 0,0133 0,32 0,0323
AKR1C3 -0,34 0,0084 -0,37 0,0044
BC068543//GBF1 0,36 0,0423 0,37 0,0386
BHLHE23 0,36 0,0179 -0,30 0,0431
BTN3A3 0,48 0,0066 0,40 0,0195
C10orf107 0,42 0,0016 0,28 0,0258
CCDC30 0,39 0,0203 0,39 0,0185
CKMT1A//RNU6-28P -0,40 0,0067 0,31 0,0325
CSH2 0,26 0,0450 -0,34 0,0121
CYP4F30P -0,33 0,0292 -0,33 0,0315
DKFZp667J0810 0,30 0,0196 0,30 0,0194
FLJ41484//GAS6-AS1 0,29 0,0359 0,58 0,0002
INSM2 0,26 0,0248 -0,31 0,0093
LRP8 -0,32 0,0350 -0,31 0,0389
LRRC37A3 0,56 0,0032 0,35 0,0492
MIR501//CLCN5 -0,51 0,0017 -0,42 0,0073
NAA15 -0,31 0,0070 0,27 0,0153
OR7E91P 0,45 0,0187 0,44 0,0232
PABPC1 0,41 0,0264 0,42 0,0229
PTPN1 0,46 0,0369 -0,52 0,0201
SLC2A13 -0,37 0,0258 -0,40 0,0164
SLC35G2 -0,30 0,0152 -0,31 0,0135
SPAG11A//SPAG11B 0,26 0,0356 0,27 0,0335
SPDYE5 -0,45 0,0366 0,44 0,0406
TESK2 0,30 0,0265 0,75 0,0000
TFPT 0,35 0,0129 0,27 0,0437
TRAV12-1//TCRA//TRA 0,46 0,0024 0,36 0,0141
U3 -0,53 0,0155 -0,54 0,0142
U6 -0,47 0,0196 -0,47 0,0197
ULK4P3 0,54 0,0092 0,58 0,0056
https://doi.org/10.1371/journal.pone.0208131.t003
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Moreover, two crucial proteins of bone extracellular matrix were assessed by qPCR after
miR-320a transfection. Gene expression of both genes, COL1A1 and BGLAP, seems to be
slightly affected by miR-320a (S5 Fig).
Cellular oxidative stress assessment
Reactive oxygen species (ROS) were detected in hOB cells using CellRox Green Reagent at 72
hours after miR-320a mimic/inhibitor transfection. An increased green fluorescence was
observed in cells transfected with miR-320a mimic compared to its respective control. More-
over, cells transfected with miR-320a inhibitor exhibited less fluorescence in relation to its
Fig 1. Functional interaction network from miR-320a-regulated genes plus the genes most related to the original list using GeneMANIA prediction server.
https://doi.org/10.1371/journal.pone.0208131.g001
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control (Fig 3). In addition, FoxO1 gene expression was evaluated in these cells resulting in an
increase in FoxO1 mRNA levels after miR-320a inhibitor transfection (S6 Fig).
Discussion
MiR-320a is overexpressed in osteoporotic bone [2], but its role in osteoblastic function was
unknown. In the present study, we overexpressed or inhibited miR-320a in hOBs and per-
formed a microarray analysis to reveal the regulated genes and pathways. Additionally, com-
prehensive functional analyses were carried out in human primary osteoblasts. Microarray
results showed a number of key osteoblast genes, together with genes involved in oxidative
stress, that were regulated by miR-320a. We also observed an alteration in osteoblast function-
ality, involving increased proliferation, reduced mineralization, and increased oxidative stress,
which might be explained by changes in this gene expression profile.
A total of 38 and 23 genes showed significant expression changes (logFC>1.5) after transfec-
tion of miR-320 mimic or inhibitor, respectively, compared to the control transfection samples.
No gene was found in both the mimic and inhibitor transfection lists. When logFC was
Fig 2. Effect of miR-320a on human osteoblast cell function. (a) cell viability, (b) proliferation, (c) Alizarin Red quantification, and (d) alkaline phosphatase activity were
determined in primary hOBs (n = 6) transfected with mimic and inhibitor of miR-320a and its respective controls. Data represent the mean ± SD. �p<0.05.
https://doi.org/10.1371/journal.pone.0208131.g002
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decreased to>1.2, a set of 32 overlapped genes was obtained, although the sign differed between
the transfections in 7 of them. As we were dealing with gene expression in primary cells, we
observed considerable differences between patients, which precluded obtaining larger logFCs.
Another limitation is that microarray assessment of the effects of miRNA-320a cannot discrimi-
nate between directly and indirectly regulated genes. Hence, we cannot rule out that many of
the altered genes after miR-320a transfection were regulated for indirect pathways. This could
explain the differences found between mimic- and inhibitor-regulated genes. Nonetheless,
using microarrays allowed us to obtain a general view of the biological pathways affected.
The bioinformatic analysis revealed that pathways involved in the osteoblastic function
may be altered after modification of miR-320a cell levels, which had not previously been
described. The other enriched pathway (best score) was that of the cellular response to
Fig 3. Cellular oxidative stress was tested using CellRox Green Reagent at 72 hours after miR-320a mimic/inhibitor transfection. Fluorescence was evaluated with the
LEICA DMIL LED fluorescence microscope and with the Leica Application Suite (Leica Microsystems).
https://doi.org/10.1371/journal.pone.0208131.g003
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cadmium and zinc ions, mostly by the overexpression of metallothioneins (MTs), which have
a role in regulating the zinc pool necessary for bone growth. Zinc has a potent stimulatory
effect on osteoblastic bone formation and an inhibitory effect on osteoclastic bone resorption.
Therefore, zinc deficiency decreases chondrocyte proliferation and metaphysis heights, along
with increased osteoclast density [22]. Apart from the specific function of MTs in homeostasis
of essential metals, they also have an antioxidant role against reactive oxygen species (ROS)
and protection against DNA damage [23]. These results helped us to focus on further func-
tional studies.
Transfection results of miR-320a in hOB showed that this miRNA led to increase of prolif-
eration but to reduce the ALP activity and mineralization capability, consistent with a loss of
osteoblastic differentiation. It is corroborated by the depletion of HOXA10 and RUNX2 gene
expression after miR-320a overexpression. Moreover, a subtle reduction of COL1A1 and
BGLAP (osteocalcin) gene expression was also detected after miR-320a overexpression. These
results suggest an explanation for the higher levels of this miRNA detected in fractured osteo-
porotic bone [2]: overexpression of this miRNA may lead to an impaired mineralization and,
consequently, to an osteoporotic phenotype.
It is worth mentioning the different effect between mimic and inhibitor, which could be
explained by the microRNA affinity to the gene target and/or the cellular levels of miR-320a.
For instance, the action of the miRNA would not be counteracted by its inhibitor if the
miRNA effect is small per se whereas an overexpression of the miRNA could increase its effect
to detectable levels.
Since cellular oxidative stress was the other pathway predicted to be affected by miR-320a,
we measured ROS in hOBs. Results consistently showed that all cells transfected with miR-
320a mimic had increased ROS levels compared to cells transfected with the control mimic.
The opposite effect was observed following miR-320a inhibition, with a reduction of ROS. In
primary cells, low ROS levels were observed as a result of normal cell metabolism, and were
controlled effectively by the potent cellular antioxidant defense system. The increased ROS lev-
els due to miR-320a transfection may stimulate cell proliferation [24], as well as upregulate
MT-1 expression as a response to oxidative stress [25]. Moreover, these increased levels of
ROS might contribute to the observed osteoblastic dysfunction [26]. In this context, FoxO1, a
transcription factor indispensable for both redox homeostasis and bone metabolism [27],
could be an intermediate element in this process since it was significantly increased after miR-
320a inhibition. However, the link between increased ROS and osteoblast dysfunction during
miR-320a overexpression remains an hypothesis at this stage and needs to be further explored.
Nevertheless, it is known that the generation of ROS (including nitric oxide, peroxide ion, etc.)
is one of the factors responsible for osteoporosis [28, 29] and this may be one of the mecha-
nisms that can explain the deleterious effect of miR-320a on bone metabolism.
In conclusion, overexpression of miR-320a produces an increase in stress oxidation levels
and a reduced mineralization capacity in osteoblastic cells. This disruption of optimal osteo-
blast function may trigger an osteoporotic phenotype.
Supporting information
S1 Fig. (a) miRIDIAN microRNA Mimic Transfection Control with Dy547 at 100 nM per-
formed in hOBs. Cell nucleus was stained with DAPI. Magnification 20x with the Leica DM IL
LED inverted microscope. (b) hOBs were transfected with mimic (100 nM) and inhibitor (400
nM) of miR-320a and the respective miRNA controls. MiRNA levels were measured 48 hours
post-transfection by qPCR. Data represent the mean ± SD (n = 2). ��p<0.01.
(JPG)
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S2 Fig. Heat map of differently expressed mRNAs in control mimic vs. mimic samples.
Experiments were performed in five hOBs samples. The heat map represents a hierarchical
cluster analysis of the differentially expressed mRNAs after a comparison of the control
mimic, first five columns, and the miR-320a mimic, five last columns (Control Mimic
-Mimic). Each row represents one mRNA and each column, a sample. The mRNA clustering
tree is shown at the top of the panel. The color scale illustrates the relative level of the corre-
sponding mRNA expression: red, higher than the reference, and blue, below the reference.
(TIF)
S3 Fig. Quantification of gene expression by real time PCR of genes significantly regulated
by miR-320a to validate microarray results.
(TIF)
S4 Fig. Heat map of differentially expressed mRNAs in inhibitor vs. control inhibitor.
Experiments were performed in five hOBs samples. The heat map represents a hierarchical
cluster analysis of the differentially expressed mRNAs after a comparison between the control
inhibitor, first five columns, and the miR-320a inhibitor, five last columns (Inhibitor–Control
inhibitor). Each row represents an mRNA and each column, a sample. The mRNA clustering
tree is shown at the top of the panel. The color scale illustrates the relative level of the corre-
sponding mRNA expression: red, higher than the reference, and blue, below the reference.
(TIF)
S5 Fig. Quantification of gene expression by real time PCR of genes involved in osteoblast
differentiation and genes of bone extracellular matrix after miR-320a mimic and inhibitor
transfection.
(TIF)
S6 Fig. Quantification of FOXO1 gene expression by real time PCR after miR-320a mimic
and inhibitor transfection (n = 5).
(TIF)
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